A biological pharmacology network to secure the risk of drug-drug interaction with nirmatrelvir/ritonavir.
Lemaitre F, Boland L, Tron C, Grégoire M, Lelong-Boulouard V, Gandia P, Goirand F, Gambier N, Boglione-Kerrien C, Franck B, Lalanne S, Devresse A, Briol S, Haufroid V, Verdier MC; SFPT Therapeutic Drug Monitoring, Treatment Personalization group (STP-PT) of the French Society of Pharmacology, Therapeutics (SFPT).
Lemaitre F, et al. Among authors: lalanne s.
Therapie. 2024 Jul 26:S0040-5957(24)00081-7. doi: 10.1016/j.therap.2024.07.003. Online ahead of print.
Therapie. 2024.
PMID: 39174455